Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J De Schepper

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Archives of Disease in Childhood|February 23, 2005
Trends in age at diagnosis of Turner syndromeG Massa, F Verlinde, J De Schepper, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 20, 2002
Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiencyK Lagrou, D Xhrouet-Heinrichs, G Massa, et al.
Maturitas|July 8, 2020
How to manage osteoporosis before the age of 50S Rozenberg, O Bruyère, P Bergmann, et al.
Journal of Clinical Pharmacology|May 11, 1999
Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteersA Van Hecken, M Depré, R Verbesselt, et al.
International Journal of Endocrinology|June 1, 2018
Adult Height after Growth Hormone Treatment at Pubertal Onset in Short Adolescents Born Small for Gestational Age: Results from a Belgian Registry-Based StudyM Thomas, D Beckers, C Brachet, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2014
Sex steroids in relation to sexual and skeletal maturation in obese male adolescentsS Vandewalle, Y Taes, T Fiers, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2013
Bone size and bone strength are increased in obese male adolescentsS Vandewalle, Y Taes, M Van Helvoirt, et al.
Bone|June 29, 2015
Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional studyM Cools, S Goemaere, D Baetens, et al.
Diabetologia|March 30, 2006
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetesI Weets, I Truyen, I Verschraegen, et al.
International Journal of Clinical Pharmacology Research|January 1, 1996
Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in manM Depré, A Van Hecken, R Verbesselt, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Archives of Disease in Childhood|February 23, 2005
Trends in age at diagnosis of Turner syndromeG Massa, F Verlinde, J De Schepper, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|April 20, 2002
Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiencyK Lagrou, D Xhrouet-Heinrichs, G Massa, et al.
Maturitas|July 8, 2020
How to manage osteoporosis before the age of 50S Rozenberg, O Bruyère, P Bergmann, et al.
Journal of Clinical Pharmacology|May 11, 1999
Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteersA Van Hecken, M Depré, R Verbesselt, et al.
International Journal of Endocrinology|June 1, 2018
Adult Height after Growth Hormone Treatment at Pubertal Onset in Short Adolescents Born Small for Gestational Age: Results from a Belgian Registry-Based StudyM Thomas, D Beckers, C Brachet, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2014
Sex steroids in relation to sexual and skeletal maturation in obese male adolescentsS Vandewalle, Y Taes, T Fiers, et al.
The Journal of Clinical Endocrinology and Metabolism|May 14, 2013
Bone size and bone strength are increased in obese male adolescentsS Vandewalle, Y Taes, M Van Helvoirt, et al.
Bone|June 29, 2015
Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional studyM Cools, S Goemaere, D Baetens, et al.
Diabetologia|March 30, 2006
Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetesI Weets, I Truyen, I Verschraegen, et al.
International Journal of Clinical Pharmacology Research|January 1, 1996
Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in manM Depré, A Van Hecken, R Verbesselt, et al.
Pageof 15